Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
Result description
The majority of multiple myeloma (MM) patients are 6+5 years of age or older at diagnosis (1). However, treatment of MM in the elderly remains challenging because older patients typically have a higher burden of chronic comorbidities, may experience increased drug-related toxicity, and are often ineligible for stem cell transplantation (2-7).
Keywords
The result's identifiers
Result code in IS VaVaI
Alternative codes found
RIV/61988987:17110/17:A1801R4X RIV/65269705:_____/17:00067547 RIV/00843989:_____/17:E0106411
Result on the web
DOI - Digital Object Identifier
Alternative languages
Result language
angličtina
Original language name
Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup
Original language description
The majority of multiple myeloma (MM) patients are 6+5 years of age or older at diagnosis (1). However, treatment of MM in the elderly remains challenging because older patients typically have a higher burden of chronic comorbidities, may experience increased drug-related toxicity, and are often ineligible for stem cell transplantation (2-7).
Czech name
—
Czech description
—
Classification
Type
Jimp - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Leukemia & Lymphoma
ISSN
1042-8194
e-ISSN
—
Volume of the periodical
58
Issue of the periodical within the volume
10
Country of publishing house
GB - UNITED KINGDOM
Number of pages
4
Pages from-to
2501-2504
UT code for WoS article
000404572000031
EID of the result in the Scopus database
2-s2.0-85015635745
Result type
Jimp - Article in a specialist periodical, which is included in the Web of Science database
OECD FORD
Hematology
Year of implementation
2017